Daewoong wins permission for Nabota in Argentina
South Korea's Daewoong Pharmaceutical Co. announced on Monday that its botulinum toxin Nabota received product approval from Argentina's National Ad...
Medytox to supply $73 mn botulinum toxin to Brazilian firm
South Korea's biopharmaceutical firm Medytox Inc. announced on Tuesday that it signed a contract with Brazilian pharmaceutical company Blau Farmaceu...
Medytox to enter China’s botulinum toxin market with Newlux
South Korean pharmaceutical company Medytox Inc. on Tuesday announced its plan to enter the Chinese market for botulinum toxins (BTX) with its cut...
Hugel resubmits application to FDA for botulinum toxin product
South Korea's biopharmaceutical company Hugel Inc., announced on Friday that it has resubmitted applications to the US Food and Drug Administration ...
Daewoong's Nabota exceeds 600,000 customers in US
South Korea's Daewoong Pharmaceutical said on Thursday that its local loyalty program for Nabota (American name: Jeuveau) in the US, a botulinum tox...
Daewoong Pharma to build third botulinum toxin plant for $746 mn
South Korea’s Daewoong Pharmaceutical next year will open a third plant to greatly expand annual output of its botulinum toxin Nabota at a cos...
Botulinum toxin resistance emerges as key factor for safe use
As demand for botulinum toxin for aesthetic purposes is globally increasing, safe use of the drug has emerged as one of the most important issues in...
Daewoong’s Nabota expands into Germany, Austria
South Korean drugmaker Daewoong Pharmaceutical Co. said on Tuesday it had launched its botulinum toxin product Nabota in Germany and Austria through i...
Dubai delegation conducts due diligence on Medytox's plant in Korea
South Korea's biopharmaceutical firm Medytox Inc. said on Monday that a high-level delegation led by Dubai Science Park (DSP) under Dubai's state-ow...
Jetema applies to test its botulinum toxin in US from July
South Korea's bio-esthetic pharmaceutical company Jetema Co. will hold clinical trials in the US to advance to the American market, the world's bigg...
US calls on 2 S.Korean pharmaceutical companies for swift end to legal battle
Following its lawsuit against Daewoong Pharmaceutical, South Korea's Medytox Inc. is waging an all-out legal war against domestic counterpart Hugel ...
Daewoong Pharma's botulinum toxin Nabota proves long-lasting effect
Daewoong Pharmaceutical said on Friday that a high-dose administration of botulinum toxin Nabota (US brand name: Jeuveau) to patients with frown wri...
Daewoong Pharma's botulinum toxin Nabota wins approval from Australia
Daewoong Pharmaceutical said on Wednesday that its botulinum toxin formulation Nabota (overseas brand name: Nuceiva) won approval in Australia on Ja...
Medytox to build plant for finished toxin products in Dubai
South Korea's biopharmaceutical company Medytox Inc. will build a plant for finished products containing botulinum toxin in the United Arab Emirates...
